Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31806543

Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2020 Jan
First author
Coleman R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Jan;21(1):5-6. doi: 10.1016/S1470-2045(19)30717-X.
    note
    Source null
    related pmid
    31806541
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2020 Mar;21(3):e121. doi: 10.1016/S1470-2045(20)30001-2.
    note
    Source null
    related pmid
    32135105
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2020 Mar;21(3):e122. doi: 10.1016/S1470-2045(20)30019-X.
    note
    Source null
    related pmid
    32135106
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2020 Mar;21(3):e123. doi: 10.1016/S1470-2045(20)30057-7.
    note
    Source null
    related pmid
    32135107
    relationship
    Comment in
  5. citation
    Lancet Oncol. 2020 Mar;21(3):e124. doi: 10.1016/S1470-2045(20)30066-8.
    note
    Source null
    related pmid
    32135108
    relationship
    Comment in
  6. citation
    Lancet Oncol. 2020 Mar;21(3):e125. doi: 10.1016/S1470-2045(20)30099-1.
    note
    Source null
    related pmid
    32135109
    relationship
    Comment in
  7. citation
    Ann Transl Med. 2020 Aug;8(16):1034. doi: 10.21037/atm.2020.04.31.
    note
    Source null
    related pmid
    32953834
    relationship
    Comment in
  8. citation
    Ann Transl Med. 2020 Aug;8(16):1038. doi: 10.21037/atm.2020.03.210.
    note
    Source null
    related pmid
    32953838
    relationship
    Comment in
  9. citation
    Ann Transl Med. 2020 Nov;8(21):1339. doi: 10.21037/atm-2020-99.
    note
    Source null
    related pmid
    33313084
    relationship
    Comment in

Authors and identifiers

  1. name
    Coleman R
    type
    Author
  2. name
    Finkelstein DM
    type
    Author
  3. name
    Barrios C
    type
    Author
  4. name
    Martin M
    type
    Author
  5. name
    Iwata H
    type
    Author
  6. name
    Hegg R
    type
    Author
  7. name
    Glaspy J
    type
    Author
  8. name
    Periañez AM
    type
    Author
  9. name
    Tonkin K
    type
    Author
  10. name
    Deleu I
    type
    Author
  11. name
    Sohn J
    type
    Author
  12. name
    Crown J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Coleman R
    type
    Author
  2. name
    Finkelstein DM
    type
    Author
  3. name
    Barrios C
    type
    Author
  4. name
    Martin M
    type
    Author
  5. name
    Iwata H
    type
    Author
  6. name
    Hegg R
    type
    Author
  7. name
    Glaspy J
    type
    Author
  8. name
    Periañez AM
    type
    Author
  9. name
    Tonkin K
    type
    Author
  10. name
    Deleu I
    type
    Author
  11. name
    Sohn J
    type
    Author
  12. name
    Crown J
    type
    Author
bibliography ids
  1. nci-bib-6d9df771f25d0fe92b97cbfc
book metadata
content sha256
804c0347cc364acbc950eb57f3f0433910728bf8677d132bf48ced479a5defb5
document type
citation
dois
  1. 10.1016/S1470-2045(19)30687-4
electronic publication date
display
2019 Dec 2
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31806543
immutable id
pubmed:31806543@804c0347cc364acbc950eb57f3f0433910728bf8677d132bf48ced479a5defb5
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
1
name
The Lancet. Oncology
nlm unique id
100957246
pages
60-72
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Jan;21(1):5-6. doi: 10.1016/S1470-2045(19)30717-X.
    note
    Source null
    related pmid
    31806541
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2020 Mar;21(3):e121. doi: 10.1016/S1470-2045(20)30001-2.
    note
    Source null
    related pmid
    32135105
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2020 Mar;21(3):e122. doi: 10.1016/S1470-2045(20)30019-X.
    note
    Source null
    related pmid
    32135106
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2020 Mar;21(3):e123. doi: 10.1016/S1470-2045(20)30057-7.
    note
    Source null
    related pmid
    32135107
    relationship
    Comment in
  5. citation
    Lancet Oncol. 2020 Mar;21(3):e124. doi: 10.1016/S1470-2045(20)30066-8.
    note
    Source null
    related pmid
    32135108
    relationship
    Comment in
  6. citation
    Lancet Oncol. 2020 Mar;21(3):e125. doi: 10.1016/S1470-2045(20)30099-1.
    note
    Source null
    related pmid
    32135109
    relationship
    Comment in
  7. citation
    Ann Transl Med. 2020 Aug;8(16):1034. doi: 10.21037/atm.2020.04.31.
    note
    Source null
    related pmid
    32953834
    relationship
    Comment in
  8. citation
    Ann Transl Med. 2020 Aug;8(16):1038. doi: 10.21037/atm.2020.03.210.
    note
    Source null
    related pmid
    32953838
    relationship
    Comment in
  9. citation
    Ann Transl Med. 2020 Nov;8(21):1339. doi: 10.21037/atm-2020-99.
    note
    Source null
    related pmid
    33313084
    relationship
    Comment in
outcomes validated
false
pmid
31806543
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
b1c484f193fc3a7eef8a47ee58e130505ee8f8c7bf4437a714fbdaaa6b1477f7
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2020 Jan
precision
month
year
2020
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31806543/
title
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial.

Preserved source evidence · Not medical advice